These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30802185)

  • 1. Effects of a Disease Management Program for Preventing Recurrent Ischemic Stroke.
    Fukuoka Y; Hosomi N; Hyakuta T; Omori T; Ito Y; Uemura J; Yagita Y; Kimura K; Matsumoto M; Moriyama M;
    Stroke; 2019 Mar; 50(3):705-712. PubMed ID: 30802185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline feature of a randomized trial assessing the effects of disease management programs for the prevention of recurrent ischemic stroke.
    Fukuoka Y; Hosomi N; Hyakuta T; Omori T; Ito Y; Uemura J; Kimura K; Matsumoto M; Moriyama M;
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):610-7. PubMed ID: 25576351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China.
    Peng B; Ni J; Anderson CS; Zhu Y; Wang Y; Pu C; Wu J; Wang J; Zhou L; Yao M; He J; Shan G; Gao S; Xu W; Cui L;
    Stroke; 2014 Feb; 45(2):515-9. PubMed ID: 24385269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of a coordinated care intervention to improve risk factor control after stroke or transient ischemic attack in the safety net: Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities (SUCCEED).
    Towfighi A; Cheng EM; Ayala-Rivera M; McCreath H; Sanossian N; Dutta T; Mehta B; Bryg R; Rao N; Song S; Razmara A; Ramirez M; Sivers-Teixeira T; Tran J; Mojarro-Huang E; Montoya A; Corrales M; Martinez B; Willis P; Macias M; Ibrahim N; Wu S; Wacksman J; Haber H; Richards A; Barry F; Hill V; Mittman B; Cunningham W; Liu H; Ganz DA; Factor D; Vickrey BG
    BMC Neurol; 2017 Feb; 17(1):24. PubMed ID: 28166784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol.
    Toell T; Boehme C; Mayer L; Krebs S; Lang C; Willeit K; Prantl B; Knoflach M; Rumpold G; Schoenherr G; Griesmacher A; Willeit P; Ferrari J; Lang W; Kiechl S; Willeit J
    BMC Neurol; 2018 Nov; 18(1):187. PubMed ID: 30400876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
    Yaghi S; Furie KL; Viscoli CM; Kamel H; Gorman M; Dearborn J; Young LH; Inzucchi SE; Lovejoy AM; Kasner SE; Conwit R; Kernan WN;
    Circulation; 2018 Jan; 137(5):455-463. PubMed ID: 29084736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
    Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K;
    Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
    Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
    Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke.
    Lange KS; Nave AH; Liman TG; Grittner U; Endres M; Ebinger M
    Stroke; 2017 Jan; 48(1):36-42. PubMed ID: 27856951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a shared team approach between nurses and doctors for improved risk factor management in survivors of stroke: a cluster randomized controlled trial.
    Olaiya MT; Kim J; Nelson MR; Srikanth VK; Bladin CF; Gerraty RP; Fitzgerald SM; Phan T; Frayne J; Cadilhac DA; Thrift AG;
    Eur J Neurol; 2017 Jul; 24(7):920-928. PubMed ID: 28488353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.
    Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L;
    Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
    Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
    Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.
    Van Schaik SM; Van den Berg-Vos RM; Weinstein HC; Bosboom WM
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1378-82. PubMed ID: 25804570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
    Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
    Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.
    Waters MF; Hoh BL; Lynn MJ; Kwon HM; Turan TN; Derdeyn CP; Fiorella D; Khanna A; Sheehan TO; Lane BF; Janis S; Montgomery J; Chimowitz MI;
    JAMA Neurol; 2016 Mar; 73(3):308-15. PubMed ID: 26747792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol.
    Boehme C; Domig L; Komarek S; Toell T; Mayer L; Dejakum B; Krebs S; Pechlaner R; Bernegger A; Mueller C; Rumpold G; Griesmacher A; Vigl M; Schoenherr G; Schmidauer C; Ferrari J; Lang W; Knoflach M; Kiechl S
    BMC Cardiovasc Disord; 2022 Aug; 22(1):347. PubMed ID: 35915405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
    Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
    Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
    Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.